CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging

Thais R. Peclat, Katie L. Thompson, Gina M. Warner, Claudia C.S. Chini, Mariana G Tarragó, Delaram Z. Mazdeh, Chunlian Zhang, Jose Zavala-Solorio, Ganesh Kolumam, Yao Liang Wong, Robert L. Cohen, Eduardo N. Chini

Research output: Contribution to journalArticlepeer-review

Abstract

Nicotinamide adenine dinucleotide (NAD) levels decline during aging, contributing to physical and metabolic dysfunction. The NADase CD38 plays a key role in age-related NAD decline. Whether the inhibition of CD38 increases lifespan is not known. Here, we show that the CD38 inhibitor 78c increases lifespan and healthspan of naturally aged mice. In addition to a 10% increase in median survival, 78c improved exercise performance, endurance, and metabolic function in mice. The effects of 78c were different between sexes. Our study is the first to investigate the effect of CD38 inhibition in naturally aged animals.

Original languageEnglish (US)
Article numbere13589
JournalAging Cell
Volume21
Issue number4
DOIs
StatePublished - Apr 2022

Keywords

  • CD38
  • NAD
  • aging
  • healthspan
  • longevity
  • mice
  • small molecule

ASJC Scopus subject areas

  • Aging
  • Cell Biology

Fingerprint

Dive into the research topics of 'CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging'. Together they form a unique fingerprint.

Cite this